Skip to main content

Uterotonic medications are critical tools for preventing and treating postpartum hemorrhage, a leading cause of maternal mortality. Some uterotonic medications can also be used to start or strengthen labor but require considerable safeguards to avoid any negative health effects for the fetus.  Join MOMENTUM on Thursday, July 25 from 8:00-9:00 a.m. EDT/ 3:00-4:00 p.m. EAT/ 5:30-6:30 IST for a webinar exploring strategies, efforts and tools related to optimizing uterotonic use to improve childbirth outcomes. Presentations will explore uterotonic use for labor induction and augmentation, with a focus on practices in India and South Asia, and new efforts to prevent postpartum hemorrhage, including findings from a global survey of national programs and a proposed evaluation strategy related to heat-stable carbetocin for Madagascar. Following presentations, participants will have the opportunity to engage with experts during a Q&A session. Live interpretation in French will be available.